Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study

OBJECTIVE: Suvorexant is a novel hypnotic drug that does not interact with the conventional γ-aminobutyric acid (GABA)-A receptor. We investigated the method by which suvorexant was introduced in insomnia patients who were taking benzodiazepine receptor agonists (BzRA). METHODS: This was a retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatano, Masakazu, Kamei, Hiroyuki, Inagaki, Risa, Matsuzaki, Haruna, Hanya, Manako, Yamada, Shigeki, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953018/
https://www.ncbi.nlm.nih.gov/pubmed/29739132
http://dx.doi.org/10.9758/cpn.2018.16.2.184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953018/
https://www.ncbi.nlm.nih.gov/pubmed/29739132
http://dx.doi.org/10.9758/cpn.2018.16.2.184

Ejemplares similares